A novel cis-acting element is involved in the promoter activity of the rat mdr1b gene

Cell Growth and Differentiation

Volumn 7, Issue 10, 1996, Pages 1369-1381

  Zhou, Ge ^a   Song, Renduo ^a   Tien Kuo, M ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; GLYCOPROTEIN P;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION REGULATION; LIVER CARCINOGENESIS; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT;

ANIMALS; BASE SEQUENCE; CELL LINE; CLONING, MOLECULAR; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENES, MDR; MICE; MOLECULAR SEQUENCE DATA; P-GLYCOPROTEIN; PROMOTER REGIONS (GENETICS); RATS;

ANIMALIA; MURINAE; RODENTIA;

EID: 0029834394     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Gottesman, M. M., and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62: 385-427, 1993.
2. Endicott, J. A., and Ling, V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem., 58: 137-171, 1989.
3. Higgins, C. F. ABC transporters: from microorganism to man. Annu. Rev. Cell Biol., 8: 67-113, 1992.
4. Chan, H. S., Thorner, P. S., Haddad, G., DeBoer, G., Gallie, B. L., and Ling, V. Multidrug resistance in cancers of childhood: clinical relevance and circumvention. Adv. Pharmacol., 24: 157-197, 1993.
5. Chen, C-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., and Roninson, I. B. Internal duplication and homology with bacterial transport protein in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell, 47: 381-389, 1986.
6. Van der Bliek, A. M., Kooiman, P. M., Schneider, C. and Borst, P. Sequence of mdr3 cDNA encoding a human p-glycoprotein. Gene, 71: 401-411, 1988.
7. Gros, P., Croop, J. and Housman, D. Mammalian multidrug resistance gene: complete cDNA sequence indicate strong homology to bacterial transport protein. Cell, 47: 371-380, 1986.
8. Gros, P., Raymond, M., Bell, J., and Housman, D. Cloning and characterization of a second member of the mouse mdr gene family. Mol. Cell. Biol., 8: 2770-2778, 1988.
9. Ueda, K., Cardarelli, C., Gottesman, M. M., and Pastan, I. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA, 84: 3004-3008, 1987.
10. Devault, A., and Gros, P. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol. Cell. Biol., 10: 1652-1663, 1990.
11. Gros, P., Ben-Neriah, Y. B., Croop, J. M., and Housman, D. E. Isolaton and expression of a complementary DNA that confers multidrug resistance. Nature (Lond.), 323: 728-731, 1986.
12. Schinkel, A. H., Smit, J. J. M., van Telingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol. C. A., van der valk, M. A., Robanus-Maandag, E. C., te Riele, H. P., Berns, A. J. M., and Borst, P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell, 77: 491-502, 1994.
13. Smit, J. J., Schinkel, A. H., Oude Elferink, R. P. J., Groen, A. K., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., Ottenhoff, R. van der Lugt, N. M. T., van Roon, M. A., van der valk, M. A., Offerhaus, G. J. A., Berns, A. J. M., and Borst. P. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver diseases. Cell, 75: 451-462, 1993.
14. Ruetz, S., and Gros, P. Enhancement of mdr2-mediated phosphatidycholine translocation by the bile salt taurocholate. J. Biol. Chem., 270: 25388-25395, 1995.
15. Roninson, I. B., Abelson, H. T., Housman, D. E., Howell, N., and Varshavsky, A. Amplification of specific DNA sequences correlates with multidrug resistance in Chinese hamster cells. Nature (Lond.), 309: 626-628, 1984.
16. Scotto, K. W., Biedler, J. L., and Melera, P. W. Amplification and expression of gene associated with multidrug resistance in mammalian cells. Science (Washington DC), 232: 751-755, 1986.
17. Riordan, J. R., Deuchars, K., Kartner, N., Alon, N., Trent, J. and Ling, V. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature (Lond.), 316: 817-819, 1985.
18. Teeter, L. D., Atsumi, S., Sen, S., and Kuo, T. DNA amplification in multidrug, cross-resistant Chinese hamster ovary cells: molecular characterization and cytogenetic localization of the amplified DNA. J. Cell Biol., 103: 1159-1166, 1986.
19. Shen, D-W., Fojo, A., Chin, J. E., Roninson, I. B., Richert, N., Pastan, I., and Gotlesman, M. M. Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science (Washington DC), 232: 643-645, 1986.
20. Bradley, G., Naik, M., and Ling, V. P-glycoprotein expression in multidrug-resistant human ovarian carcinoma cell lines. Cancer Res., 49: 2790-2796, 1990.
21. Fairchild, C. R., Ivy, S. P., Kao-Shan, C-S., Whang-Peng, J., Rosen, N., Israel, M. A., Melera, P. W., Cowan, K. H., and Goldsmith, M. E. Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 84: 7701-7705, 1987.
22. Van der Bliek, A, M., Baas, F. Van der Velde-Koerts, T., Biedler, J. L., Meyers, M. B., Ozols, R. F., Hamilton, T. C., Joenje, H., and Borst, P. Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res., 48: 5927-5932, 1988.
23. Sugimoto, Y., Roninson, I. B., and Tsuruo, T. Decreased expression of the amplified mdr1 gene in revertants of multidrug-resistant human myelogenous leukemia K562 occurs without loss of amplified DNA. Mol. Cell Biol., 7: 4549-4552, 1987.
24. Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S-L. Gazdar, A., Pirker, R. Green, A., Crist, W., Brodeur, G. M., Lieber, M., Cossman, J., Gottesman, M. M., and Pastan, I. Expression of a multidrug resistance gene in human cancer. J. Natl. Cancer Inst., 81: 116-124, 1989.
25. Croop, J. M., Raymond, M., Haber, D., Devault, A., Arceci, R. J., Gros, P., and Housman, D. E. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol. Cell Biol., 9: 1346-1350, 1989.
26. Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., and Pastan, I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA, 84: 265-269, 1987.
27. Thiebaut, F., Tsuruo, T. T., Hamada, H., Gottesman, M. M., Pastan, I., and Willingham, M. C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA, 84: 7735-7738, 1987.
28. Thorgeirsson, S. S., Huber, B. E., Sorrell, S., Fojo, A., Pastan, I., and Gottesman, M. M. Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. Science (Washington DC), 236: 1120-1121, 1987.
29. Teeter, L. D., Becker, F. F., Chisari, F. V., Li, D. J., and Kuo, M. T. Over-expression of the multidrug resistance gene mdr3 in spontaneous and chemically induced mouse hepatocellular carcinomas. Mol. Cell Biol., 10: 5728-5735, 1990.
30. Gant, T. W., Silverman, J. A., Bisgaard, H. C., Burt, R. K., Marino, P. A., and Thorgeirsson, S. S. Regulation of 2-acetylaminofluorene- and 3 methylcholanthrene-mediated induction of multidrug resistance and cytochrome p4501A gene family expression in primary hepatocyte cultures and rat liver. Mol. Carcinog., 4: 499-509, 1991.
31. Teeter, L. D., Chan, J. Y., and Kuo, M. T. Coordinate activation of multidrug resistance (P-glycoprotein) genes mdr2 and mdr3 during mouse liver regeneration. Mol. Carcinog., 4: 358-361, 1991.
32. Teeter, L. D., Estes, M., Chan, J. Y., Atassi, H., Sell, S., Becker, F. F., and Kuo, M. T. Activation of distinct multidrug-resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis. Mol. Carcinog., 8: 67-73, 1993.
33. Raymond, M., and Gros, P. Cell-specific activity of cis-acting regulatory elements in the promoter of the mouse multidrug resistance gene mdr1. Mol. Cell Biol., 10: 6036-6040, 1990.
34. Cohen, D., Piekarz, R. L., Hsu, S. I., DePinho, R. A., Carrasco, N., and Horwitz, S. B. Structural and functional analysis of the mouse mdr1b gene promoter. J. Biol. Chem., 266: 2239-2244, 1991.
35. Silverman, J., and Hill, B. A. Characterization of the basal and carcinogen regulatory elements of the rat mdr1b promoter. Mol. Carcinog., 13: 50-59, 1995.
36. Song, R., Ikeguchi, M., Zhou, G., and Kuo, M. T. Identification and characterization of a hepatoma cell-specific enhancer in the mouse multidrug resistance mdr1b promoter. J. Biol. Chem., 270: 25468-25474, 1995.
37. Silverman, J. A., Raunio, H., Gant, T. W., and Thorgeirsson, S. S. Cloning and characterization of a member of the rat multidrug resistance (mdr) gene family. Gene, 106: 229-236, 1991.
38. Ikeguchi, M., Teeter, L. D., Eckersberg, T., Ganapathi, R., and Kuo, M. T. Structural and functional analyses of the promoter of the murine multidrug resistance gene mdr3/mdr1a reveal a negative element containing the AP-1 binding site. DNA Cell Biol., 10: 639-649, 1991.
39. Teeter, L. D., Sanford, J. A., Sen, S., Stallings, R. L., Siciliano, M. J., and Kuo, M. T. Multidrug-resistant phenotype cosegregates with an amplified gene in somatic cell hybrids of drug-resistant Chinese hamster ovary cells and drug-sensitive murine cells. Mol. Cell. Biol., 6: 4268-4273, 1986.
40. Boulikas, T. A compilation and classification of DNA binding sites for protein transcription factors from vertebrates. Crit. Rev. Eukaryotic Gene Expression, 4: 117-321, 1994.
41. El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., and Vogelstein, B. Definition of a consensus binding site for p53. Nat. Genet., 1: 45-49, 1992.
42. Chin, K-V., Ueda, K., Pastan, I., and Gottesman, M. M. Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science (Washington DC), 255: 459-462, 1992.
43. Goldsmith, M. E., Gudas, J. M., Schneider, E., and Cowan, K. H. Wild-type p53 stimulates expression from the human multidrug resistance promoter in a p53-negative cell line. J. Biol. Chem., 270: 1894-1898, 1995.
44. Zastawny, R. L., Salvino, R., Chen, J., Benchimol, S., and Ling, V. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53. Oncogene, 8: 1529-1535, 1993.
45. Xanthopoulos, K. G., Prezioso, V. R., Chen, W. S., Sladek, F. M., Cortese, R., and Darnell, J. E., Jr. The different tissue transcription patterns of genes for HFN-1, C/EBP, HNF-3, and HNF-4, protein factors that govern liver-specific transcription. Proc. Natl. Acad. Sci. USA, 88: 3807-3811, 1991.
46. Grange, T., Roux, J., Rigaud, G., and Pictet, R. Cell-type specific activity of two glucocorticoid responsive units of rat tyrosine aminotransferase gene is associated with multiple binding sites for C/EBP and a novel liver-specific nuclear factor. Nucleic Acids Res., 19: 131-139, 1991.
47. Sen, R., and Baltimore, D. Multiple factors interact with the immunogtobulin enhancer sequences. Cell, 46: 705-716, 1986.
48. van Straaten, F., Mueller, R., Curran, T., van Beveren, C., and Verma, I. M. Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-fos protein. Proc. Natl. Acad. Sci. USA, 80: 3183-3187, 1983.
49. Cornwall, M. M. The human multidrug resistance gene: sequences upstream and downstream of the initiation site influence transcription. Cell Growth & Differ., 1: 607-615, 1990.
50. Goldsmith, M. E., Madden, M. J., Morrow, C. S., and Cowan, K. H. A. A Y-box consensus sequence is required for basal expression of the human multidrug resistance (mdr1) gene. J. Biol. Chem., 268: 5856-5860, 1993.
51. Cornwell, M. M., and Smith, D. E. Sp1 activates the MDR1 promoter through one of two distinct G-rich region that modulate promoter activity. J. Biol. Chem., 268: 19505-19511, 1993.
52. Combates, N. J., Rzepka, R. W., Chen, Y-N. P., and Cohen, D. NF-IL-6, a member of the C/EBP family of transcription factors, binds and trans-activates the human MDR1 gene promoter. J. Biol. Chem., 269: 29715-29719, 1994.
53. McCoy, C., Smith, D. E., and Cornwell, M. M. 12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1. Mol. Cell. Biol., 15: 6100-6108, 1995.
54. Cohen, D., Yu, L., Rzepka, R., and Horwitz, S. B. Identification of two nuclear protein binding sites and their role in the regulation of the murine multidrug resistance mdr1a promoter. DNA Cell Biol., 13: 641-649, 1994.
55. Yu, L., Cohen, D., Piekarz, R. L., and Horwitz, S. B. Three distinct nuclear protein binding sites in the promoter of the murine multidrug resistance mdr1b gene. J. Biol. Chem., 268: 7520-7526, 1993.
56. Yu, L., Wu, Q., Yang C-P. H., and Horwitz, S. B. Coordination of transcription factors, NF-Y and C/EBP in the regulation of the mdr1b promoter. Cell Growth & Differ., 6: 1505-1512, 1995.
57. Teeter, L. D., Eckersberg, T., Tsai, Y., and Kuo, M. T. Analysis of the Chinese hamster P-glycoprotein/multidrug-resistance gene pgpl reveals that the AP-1 site is essential for full promoter activity. Cell Growth & Differ., 2: 429-437, 1991.
58. Luckow, B., and Schutz, G. CAT construction with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res., 15: 5490-5493, 1987.
59. Higuchi, R. Recombinant PCR. In: M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J White (eds.), PCR protocols: A Guide Methods and Applications pp. 177-183. San Diego: Academic Press, Inc., 1990.
60. Hankinson, O. Single-step selection of clones of a mouse hepatoma line deficient in aryl hydrocarbon hydroxylase. Proc. Natl. Acad. Sci. USA, 96: 373-376, 1979.
61. Kawai, S., and Nishizawa, M. New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol. Cell Biol., 4: 1172-1174, 1984.
62. Hattori, M., Tugores, A., Veloz, L., Karin, M., and Brenner, D. A. A simplified method for the preparation of transcriptionally active liver nuclear extracts. DNA Cell Biol., 9: 777-781, 1990.
63. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11: 1475-1489, 1983.
64. Ohlsson, H., and Edlund, T. Sequence-specific interaction of nuclear factors with the insulin gene enhancer. Cell, 45: 35-44, 1988.